Hong Yuan Holding Group HGYN

Q2 FY2026 · ended Jun 30, 2026 · Revenue $32,161, -71.5% YoY · Filed Sep 18, 2026

Hong Yuan Holding Group (HGYN) files with the SEC under industry code 2821, Plastic Materials, Synth Resins & Nonvulcan Elastomers. In Q2 of fiscal 2026, the quarter ended Jun 30, 2026, it reported revenue of $32,161 and a net loss of $94,404. As of Jun 30, 2026 it held $13,365 in cash and investments and $4,460 in total debt.

Revenue
$32,161
-71.5% vs year-ago quarter
Net income
$-94,404
-414.2% vs year-ago quarter
Operating cash flow
$-7,864
-169.4% vs year-ago quarter
Free cash flow
$-14.36M
EPS
$-0.00
-400.0% vs year-ago quarter
Dividend per share
None
Shares outstanding
74.64M
+0.0% vs year-ago quarter
Net cash
$8,905
Q2 FY2026
Operating margin
-16.4%
TTM

Company profile

Industry
Plastic Materials, Synth Resins & Nonvulcan Elastomers (SIC 2821)
Listed as
HGYN (OTC)
Fiscal year ends
December 31
Incorporated in
NV
Headquarters
Chengdu High-Tech Zone
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1324759
Former names
Cereplast Inc (until May 25, 2021)

Other Plastic Materials, Synth Resins & Nonvulcan Elastomers companies

Key figures

Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.

Line
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Revenue
$32,161
$43,697
$225,547
$258,329
$112,812
Operating income
-$95,473
-$94,567
$42,687
$55,770
$37,884
Net income
-$94,404
-$93,346
$39,166
$48,622
$30,042
Diluted EPS
-$0.00
-$0.00
$0.00
$0.00
$0.00
Operating cash flow
-$7,864
-$3,420
$382
-$26,917
$11,329
Total assets
$632,778
$577,926
$611,315
$430,222
$305,137
Total liabilities
$779,288
$647,983
$591,669
$476,361
$404,181
Stockholders' equity
-$228,854
-$152,447
-$62,738
-$112,052
-$162,371
Cash and investments
$13,365
$6,444
$16,747
$12,610
$45,238
Total debt
$4,460
$4,326
$9,987
$19,491
$28,853

Recent SEC filings

Recent SEC filings
Form Description Filed Period
10-Q Quarterly report Sep 18, 2026 Jun 30, 2026
10-K/A Amended annual report Sep 14, 2026 Dec 31, 2025
10-Q Quarterly report Jun 22, 2026 Mar 31, 2026
10-K Annual report May 8, 2026 Dec 31, 2025
8-K/A Amended current report
Officer or director change
Jan 13, 2026 Oct 9, 2025
8-K Current report
Officer or director change
Jan 9, 2026 Jan 7, 2026

Source: SEC EDGAR filings. This is company-reported data, not investment advice.